Symposium Page
Skip Ribbon Commands Skip to main content

International Evidence-Based Guidelines on Minimally Invasive Pancreas Resection (IG-MIPR)

Monday-Tuesday, March 18-19, 2019
Eden Roc Hotel, Miami Beach Florida

About Event

 Overview

This conference will focus on international evidence-based guidelines on minimally invasive pancreas resection surgery (MIPR) that aim to give guidance to surgeons, hospital administrators, patients and medical societies on the outcome and direction to be taken regarding this challenging type of surgery. The conference will also aim to identify areas in which collaborative research is needed. ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

Goal
International experts in the field of pancreas surgery will gather to develop MIPR Guidelines based on literature review on PICO and non-PICO questions related to left sided pancreatectomy, central pancreatectomy, pancreatoduodenectomy, patient selection, techniques, training and implementation and instrumentation. 

Chair​
Horacio Asbun, M.D., FACS

Co-Chairs​
Professor Mo Abu-Hilal
Professor Marc Besselink 
Michael L. Kendrick, M.D.
Herbert J. Zeh, III, M.D.





​​​​​​

​​​​​​​​​​​​​​​
Topics this year.

Topics This Year

  • Guidelines Development
  • Central Pancreatectomy
  • Learning Curve
  • Minimally Invasive Pancreas Resection Surgery
  • Pancreatectomy
  • Pancreatoduodenectomy
  • Patient Selection
  • When to Convert
Topics this year.

Who Should Attend

  • Physicians who treat pancreatic diseases
  • Fellowship Program Directors
  • Institutional Guidelines Developers
  • Minimally Invasive Surgeons
Sponsorship & Exhibit Information

Sponsorship & Exhibit Information

On behalf of the symposium directors and the Baptist Health Continuing Medical Education Department we are pleased to invite you and your company to participate as a sponsor and exhibitor at our upcoming event.

Learn more
International Attendees

International Attendees

Baptist Health South Florida is pleased to extend a discount to International Healthcare Professionals. Availability of this discount is limited.

Upcoming Meetings

Upcoming Meetings

Visit our Continuing Medical Education Website for upcoming symposiums, as well as our local conferences and online courses, both available at no charge.

Learn More

Agenda

07:15 AM

Continental Breakfast and Visit Exhibits

Continental Breakfast and Visit Exhibits

07:45 AM

Welcome and Introductions

Welcome and Introductions

07:55 AM

SESSION I: Left Pancreas

SESSION I: Left Pancreas

08:00 AM

PICO Questions: 1-6

1. Should MIS left pancreatectomy versus open left pancreatectomy be used (regardless of indications)?
2. Should MIS left pancreatectomy versus open left pancreatectomy be used for treatment of pancreatic ductal adenocarcinoma?
3. Should MIS left pancreatectomy versus open left pancreatectomy be used for treatment of left-sided pancreatic adenocarcinoma with vascular resection?
4a. Should staples versus another type of closure be used for stump closure in MIS left pancreatectomy?
4b. Should staple-line reinforcement versus no reinforcement be used for stump closure in MIS left pancreatectomy when a stapler is used?
5. Should MIS spleen-preserving left pancreatectomy versus open spleen-preserving left pancreatectomy be used?
6. Should laparoscopic left pancreatectomy versus robotic left pancreatectomy be used for treatment of left-sided pancreatic lesions?​​

PICO Questions: 1-6
1. Should MIS left pancreatectomy versus open left pancreatectomy be used (regardless of indications)?
2. Should MIS left pancreatectomy versus open left pancreatectomy be used for treatment of pancreatic ductal adenocarcinoma?
3. Should MIS left pancreatectomy versus open left pancreatectomy be used for treatment of left-sided pancreatic adenocarcinoma with vascular resection?
4a. Should staples versus another type of closure be used for stump closure in MIS left pancreatectomy?
4b. Should staple-line reinforcement versus no reinforcement be used for stump closure in MIS left pancreatectomy when a stapler is used?
5. Should MIS spleen-preserving left pancreatectomy versus open spleen-preserving left pancreatectomy be used?
6. Should laparoscopic left pancreatectomy versus robotic left pancreatectomy be used for treatment of left-sided pancreatic lesions?​​

09:45 AM

Panel Discussion with Audience Response

Panel Discussion with Audience Response

09:55 AM

SESSION II: Central Pancreas

SESSION II: Central Pancreas

10:15 AM

PICO Question 7:

​​Should​ MIS central pancreatectomy versus open central pancreatectomy be used?​

PICO Question 7:

​​Should​ MIS central pancreatectomy versus open central pancreatectomy be used?​

10:30 AM

Panel Discussion with Audience Response

Panel Discussion with Audience Response

11:00 AM

Break and Visit Exhibits

Break and Visit Exhibits

11:25 AM

SESSION III: Head of Pancreas

SESSION III: Head of Pancreas

11:30 AM

PICO Questions: 8-12

8. Should MIS pancreatoduodenectomy versus open pancreatoduodenectomy be used (regardless of indications)?
9. Should MIS pancreatoduodenectomy versus open pancreatoduodenectomy be used for treatment of peri-ampullary adenocarcinoma and pancreatic ductal adenocarcinoma?
10. Should MIS pancreatoduodenectomy versus open pancreatoduodenectomy be used for treatment of pancreatic head adenocarcinoma after neoadjuvant therapy?
11. Should MIS pancreatoduodenectomy versus open pancreatoduodenectomy be used for treatment of pancreatic head ductal adenocarcinoma requiring vascular resection?
12. Should laparoscopic pancreatoduodenectomy versus robotic pancreatoduodenectomy be used for treatment of pancreatic head lesions?​

PICO Questions: 8-12
8. Should MIS pancreatoduodenectomy versus open pancreatoduodenectomy be used (regardless of indications)?
9. Should MIS pancreatoduodenectomy versus open pancreatoduodenectomy be used for treatment of peri-ampullary adenocarcinoma and pancreatic ductal adenocarcinoma?
10. Should MIS pancreatoduodenectomy versus open pancreatoduodenectomy be used for treatment of pancreatic head adenocarcinoma after neoadjuvant therapy?
11. Should MIS pancreatoduodenectomy versus open pancreatoduodenectomy be used for treatment of pancreatic head ductal adenocarcinoma requiring vascular resection?
12. Should laparoscopic pancreatoduodenectomy versus robotic pancreatoduodenectomy be used for treatment of pancreatic head lesions?​

12:15 PM

Panel Discussion with Audience Response

Panel Discussion with Audience Response

12:45 PM

Lunch and Learn

Lunch and Learn

01:10 PM

From the OR to the Kitchen

​Michael Zinner, M.D.​

From the OR to the Kitchen

​Michael Zinner, M.D.​

01:40 PM

SESSION I: Patients

SESSION I: Patients

01:45 PM

Non-PICO Questions: 13-14

13. Are there contraindications for MIPR with regard to patient age, obesity, complex prior abdominal operations, etc.?
14. Does MIPR offer advantages over open approach for patients with elevated comorbidity index?

Non-PICO Questions: 13-14
13. Are there contraindications for MIPR with regard to patient age, obesity, complex prior abdominal operations, etc.?
14. Does MIPR offer advantages over open approach for patients with elevated comorbidity index?

02:05 PM

Panel Discussion with Audience Response

Panel Discussion with Audience Response

02:20 PM

SESSION II: Technique

SESSION II: Technique

02:25 PM

Non-PICO Questions: 15-16

15. Optimal techniques for control of hemorrhage during MIPR? (Delphi)
16. When should a s​urgeon consider conversion to an open approach (contributing factors and timing of conversion)? (Delphi)​

Non-PICO Questions: 15-16
15. Optimal techniques for control of hemorrhage during MIPR? (Delphi)
16. When should a s​urgeon consider conversion to an open approach (contributing factors and timing of conversion)? (Delphi)​

02:45 PM

Panel Discussion with Audience Response

Panel Discussion with Audience Response

03:15 PM

Adjourn

Adjourn

07:30 AM

Continental Breakfast and Visit Exhibits

Continental Breakfast and Visit Exhibits

07:55 AM

Welcome and Introductions

Welcome and Introductions

08:00 AM

SESSION III: Training and Implementation

SESSION III: Training and Implementation

08:00 AM

Non-PICO - Surgeon Factors: Questions: 17-19

17. What is the value of formal HPB and MIS training in MIPR? (Delphi)
18. Does surgeon volume affect outcomes after MIPR? 
19. Are there recommended prerequisites for surgeons embarking on laparoscopic or robotic MIPS? Should the presence of a second surgeon be required during the early learning curve? (access difficulty score) (Delphi)

Non-PICO - Surgeon Factors: Questions: 17-19
17. What is the value of formal HPB and MIS training in MIPR? (Delphi)
18. Does surgeon volume affect outcomes after MIPR? 
19. Are there recommended prerequisites for surgeons embarking on laparoscopic or robotic MIPS? Should the presence of a second surgeon be required during the early learning curve? (access difficulty score) (Delphi)

08:30 AM

Panel Discussion with Audience Response

Panel Discussion with Audience Response

09:00 AM

Non-PICO - Hospital Setting: Questions: 20-21

20. Does center volume affect outcomes of MIPR? 
21. What are essential requirements for an MIPR program? (Delphi)

Non-PICO - Hospital Setting: Questions: 20-21
20. Does center volume affect outcomes of MIPR? 
21. What are essential requirements for an MIPR program? (Delphi)

09:20 AM

Panel Discussion with Audience Response

Panel Discussion with Audience Response

09:40 AM

SESSION IV: Instrumentation

SESSION IV: Instrumentation

09:40 AM

Non-PICO Questions: 22-24

22. Is there any advantage for 3D, 4K visualization for MIPR (PD/DP)? (Delphi)
23. Energy devices: Safety? Advantages? Tricks and tips. (Delphi)
24. Is there a need to develop new instrumentation for MIPR?

Non-PICO Questions: 22-24
22. Is there any advantage for 3D, 4K visualization for MIPR (PD/DP)? (Delphi)
23. Energy devices: Safety? Advantages? Tricks and tips. (Delphi)
24. Is there a need to develop new instrumentation for MIPR?

10:10 AM

Break

Break

10:40 AM

Panel Discussion with Audience Response

Panel Discussion with Audience Response

11:10 AM

SESSION V: Accountability

SESSION V: Accountability

11:10 AM

Non-PICO Questions: 25-27

25. What is the value and current status of registries for MIPR? (Delphi)
26. For MIPR PD, should it be mandatory to: (Delphi) 
○ Follow outcomes?
○ Belong to a registry?
27. What should be the role of surgical societies in the development and implementation of MIPR? (Delphi)

Non-PICO Questions: 25-27

11:40 AM

Panel Discussion with Audience Response

Panel Discussion with Audience Response

12:10 PM

Validation Committee Report

Validation Committee Report

12:40 PM

Lunch (working lunch for steering committee)

Lunch (working lunch for steering committee)

12:40 PM

SESSION VI: Recommendations

SESSION VI: Recommendations

02:00 PM

Review and Vote on the Guidelines

Review and Vote on the Guidelines

04:00 PM

Adjourn

Adjourn

Faculty

Horacio Asbun, M.D., FACS

Horacio Asbun, M.D., FACS

Chief, Hepatobiliary and Pancreas Surgery
Miami Cancer Institute
Miami, Florida
Adjunct Professor of Surgery Mayo Clinic College of Medicine & Sciences
Jacksonville, Florida

Professor Mo Abu-Hilal

Professor Mo Abu-Hilal

Surgeon, Liver Surgery
Southampton General Hospital 
Spire Southampton Hospital 
Wessex Nuffield Hospital, Chandlers Ford 
United Kingdom

Professor Marc Besselink

Professor Marc Besselink

Professor of Pancreatic and Hepatobiliary Surgery
University of Amsterdam 
Amsterdam, Holland

Michael L. Kendrick, M.D.

Michael L. Kendrick, M.D.

Chair, Hepatobiliary and Pancreas Surgery, Department of Surgery
Mayo Clinic Cancer Center
Rochester, Minnesota

Herbert J. Zeh, III, M.D.

Herbert J. Zeh, III, M.D.

Professor and Chair Department of Surgery 
University of Texas Southwestern Medical Center
Dallas, Texas

Professor Mo Abu-Hilal

Professor Mo Abu-Hilal

Surgeon, Liver Surgery
Southampton General Hospital 
Spire Southampton Hospital 
Wessex Nuffield Hospital, Chandlers Ford 
United Kingdom

Adnan A. Alseidi, M.D., EdM, FACS

Adnan A. Alseidi, M.D., EdM, FACS

General Surgeon
Virginia Mason Medical Center
Seattle Washington

Horacio Asbun, M.D., FACS

Horacio Asbun, M.D., FACS

Chief, Hepatobiliary and Pancreas Surgery
Miami Cancer Institute
Miami, Florida
Adjunct Professor of Surgery Mayo Clinic College of Medicine & Sciences
Jacksonville, Florida

Professor Marc Besselink

Professor Marc Besselink

Professor of Pancreatic and Hepatobiliary Surgery
University of Amsterdam 
Amsterdam, Holland

Michael L. Kendrick, M.D.

Michael L. Kendrick, M.D.

Chair, Hepatobiliary and Pancreas Surgery, Department of Surgery
Mayo Clinic Cancer Center
Rochester, Minnesota

Song-Cheol Kim, M.D., Ph.D

Song-Cheol Kim, M.D., Ph.D

Professor, Division of Hepatobiliary Surgery
University of Ulsan College of Medicine and Asan Medical Center
Seoul, Korea

Barish H. Edil, M.D., FACS

Barish H. Edil, M.D., FACS

Chair, Department of Surgery 
Gastrointestinal Cancers Clinic at Stephenson Cancer Center
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 

Melissa Hogg, M.D.

Melissa Hogg, M.D.

Surgeon, Gastrointestinal Surgical Oncology
UPMC Hillman Cancer Center 
Pittsburgh, Pennsylvania

David Kooby, M.D., FACS

David Kooby, M.D., FACS

Professor, Division of Surgical Oncology, Department of Surgery 
Director of Minimally Invasive GI Surgical Oncology
Emory University School of Medicine
Chief, Emory Surgery, Northern Arc
Director of Surgical Oncology and Chief of General Surgery
Emory Saint Joseph's Hospital 
Atlanta, Georgia

Igor E. Khatkov, M.D. Ph.D

Igor E. Khatkov, M.D. Ph.D

Head Chair of Faculty and Surgery 
Professor of General Surgery
Moscow State University of Medicine and Dentistry
Moscow, Russia

Yi-Ping Mou, M.D., Ph.D.

Yi-Ping Mou, M.D., Ph.D.

​Professor, Department of Gastrointestinal-Pancreatic Surgery
Zhejiang Provincial Peoples’ Hospital
Hangzhou, Zhejiang Province, China ​

Masafumi Nakamura

Masafumi Nakamura

Professor, Department of Surgery and Oncology
Department of Clinical Medicine 
Faculty of Medical Sciences
Kyushu University

C. Palanivelu, MS, MCh, DNB, FACS, FRCS (Hon) Ed.

C. Palanivelu, MS, MCh, DNB, FACS, FRCS (Hon) Ed.

Chairman, GEM Hospital and Research Centre
Professor and Director, Institute of Gastroenterology and Minimal Access Surgery
Managing Trustee, GEM Digestive Diseases Foundation – Charitable Trust
India

​​

Professor Sailesh V. Shrikhande

Professor Sailesh V. Shrikhande

Professor of Surgery, Head of GI and HPB Surgical Service Department of Surgical Oncology and Convener of GI, Disease Management Group 
Tata Memorial Center
Mumbai, India

R. Mathew Walsh, M.D.

R. Mathew Walsh, M.D.

Professor, Case Western Reserve University, Department of Surgery
Department Chair, General Surgery, Cleveland Clinic
Cleveland, Ohio

Herbert J. Zeh, III, M.D.

Herbert J. Zeh, III, M.D.

Professor and Chair Department of Surgery 
University of Texas Southwestern Medical Center
Dallas, Texas

Amer Abas

Amer Abas

Mou Abu Hilal, Supervisor

Mou Abu Hilal, Supervisor

Horacio Asbun, Supervisor

Horacio Asbun, Supervisor

Alberto Balduzzi

Alberto Balduzzi

Marc Besselink, Supervisor

Marc Besselink, Supervisor

Alessandro Coppola

Alessandro Coppola

Francisco de Leon

Francisco de Leon

Thijs de Rooij

Thijs de Rooij

Caitlan Hester

Caitlan Hester

Maarten Korrel

Maarten Korrel

Nuria Lluis

Nuria Lluis

Sanne Lof

Sanne Lof

Alma Moekotte

Alma Moekotte

Dominic Sanford

Dominic Sanford

Nicky Van Der Heijde

Nicky Van Der Heijde

Jony Van Hilst

Jony Van Hilst

Frederique Vissers

Frederique Vissers

Maurice Zwart

Maurice Zwart

Bergthor Björnsson

Bergthor Björnsson

Ugo Boggi

Ugo Boggi

Michael D’Angelica

Michael D’Angelica

Safi Dokmak

Safi Dokmak

Bjorn Edwin

Bjorn Edwin

Christina Feronne

Christina Feronne

Nicolas Jarufe

Nicolas Jarufe

Rohan Jeyarajah

Rohan Jeyarajah

Tobias Keck

Tobias Keck

Igor Khatkov

Igor Khatkov

Dave Kooby

Dave Kooby

John Martinie

John Martinie

Nipun Merchant

Nipun Merchant

C. Palanivelu

C. Palanivelu

Patrick Pessaux

Patrick Pessaux

Ignasi Poves

Ignasi Poves

Patricio Polanco

Patricio Polanco

John Stauffer

John Stauffer

Chung-Ngai Tang

Chung-Ngai Tang

Chuck Vollmer

Chuck Vollmer

Christopher L. Wolfgang

Christopher L. Wolfgang

Amer Zureikat

Amer Zureikat

Kevin Conlon, Validation Committe Chair

Kevin Conlon, Validation Committe Chair

​​​​​​​

Registration

Registration Fees

2019 Rates
Physicians $150
Other Healthcare Professionals $95*
Baptist Health Employees $70
Fellows/Residents $70**​

International Attendees​

​Registration fee includes Continental Breakfast, Breaks and Lunch on Monday and Tuesday.

**Registration must be accompanied by a letter from the Fellowship/Residency Director.


The following options are available to expedite your symposium registrations:

Mail registration with check payment only to
Baptist Health CME Department,
8900 North Kendall Drive,
Miami, Florida 33176.

Registration Form

Register online (Master Card, Visa, American Express)

Registration Online
Guest Attendance Policy

All symposium activities (including educational sessions, meal functions, exhibit hall, etc.) are exclusively reserved for registered symposium attendees. Non-registered guests (including children, family members, colleagues, etc.) are not allowed in the symposium areas. Badges provided at registration are required for entrance into all functions and will be strictly enforced.

  

 In consideration of the Americans with Disabilities Act, please contact us to determine your special service requirements.​

 

Cancelation Policy
Changes may occur that are beyond our control. In the unforeseen event the symposium is canceled, Baptist Health will refund attendees the entire amount of their registration fees. If you are traveling from outside of the area, we strongly suggest purchasing travel insurance.

​​​​​​​​​​​​​​​​

Location & Accommodations

Location & Accommodations

The legendary Eden Roc Hotel offers oceanfront accommodations, elegant amenities and impeccable service for the ultimate getaway. To learn more about the Eden Roc Hotel, go to nobuedenroc.com.

Make your hotel reservation now by calling 855-433-3676 or going to Book your group rate for Baptist Health Event 2019 to receive the special group rate of $299, plus applicable taxes.

Hurry! Make your reservation today. The special group rate ends Saturday, February 23, 2019. Rates are based on availability. ​ 

For additional tourist information, including a host of annual art festivals and events, please visit miamiandbeaches.com​.

​​
​​​​​

Contact Us

To help us serve you better, please fill out the form below completely.

To expedite your request, you can contact us directly by phone at 78​6-596-2398.

You may also mail your request to:

Continuing Medical Education Department
Baptist Health South Florida​
8900 N. Kendall Drive​
Miami, Florida 33176

 

​​​​​​​​​​
Submit